Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Pfizer says patient dies after receiving hemophilia drug in trial - 2Flu season is just beginning, but doctors are already on high alert
- 3East Germany Somehow Built a Real Sports Car and It Was Wild
- 4Cocoa Prices Settle Lower on Expectations of Adequate Supplies
- 5Best Getaway destination: Ocean side, Mountain, or City
- Research institutions tout the value of scholarship that crosses disciplines – but academia pushes interdisciplinary researchers out
- UK clothing inflation climbs as Middle East turmoil threatens wider price rises
- Some are walking out. Some are shouting. Some are oblivious. How kids are reacting to THAT 'Wicked: For Good' scene
- Dramatic Dominance d: A Survey of \Feelings in front of an audience\ Theater Play
- Supercharge Your Remote Work Arrangement with These Game-Changing Instruments
- Relish the World: Notable Caf\u00e9s You Really want to Attempt
- Nigeria’s return to Windsor castle signals new era in UK economic partnership
- Germany's Pistorius: NATO protects Europe from Iranian missiles
- 2 of Earth's rarest lightning phenomena captured simultaneously in once-in-a-lifetime photo
